Hepatocellular Carcinoma and Hepatotoxicity
1,814 views · Published 3 July 2018 · 22:00 · Indexed 26 September 2026
Channel: Michigan Medicine · 2018 · Education
Natalyia Razumilava, MD, discusses the risks and testing for hepatocellular carcinoma (HCC), how many are meeting the Milan criteria at the time of diagnosis, the impact of a structured HCC surveillance program on outcomes and the newer GALADUS score for HCC diagnosis. She also addresses hepatotoxicity, herbal and dietary supplement induced liver injury and the leading causes of drug-induced liver injury (DILI) in children. Presented at the U-M 20th Annual Liver Disease Wrap Up CME. Learn more about liver disease and hepatology services at Michigan Medicine: https://www.uofmhealth.org/conditions-treatments/digestive-and-liver-health/liver-disease-and-hepatology
More from this channel
-
2:21
Breast cancer and osteoporosis: the link between them
-
4:21
Caregivers benefit from cancer support programs, U-M study f
-
1:46
Our Global Challenge
-
2:32
UMHS honored by AHA for quality, safety
-
2:26
Students for Jamaica: Hagley Gap
-
1:18
Who will voters pick to tackle nation's healthcare problems?
-
3:21
United Way helps our community thrive
-
1:32
How giving to United Way helps the homeless